158 related articles for article (PubMed ID: 33388010)
1. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome.
Bruckert E; Desamericq G; Khachatryan A; Ngo P; Gusto G; Sorio-Vilela F
Rev Cardiovasc Med; 2020 Dec; 21(4):643-650. PubMed ID: 33388010
[TBL] [Abstract][Full Text] [Related]
2. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
4. Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III.
Alanezi M; Yan AT; Tan MK; Bourgeois R; Malek-Marzban P; Beharry R; Alkurtass S; Gyenes GT; Nadeau PL; Nwadiaro N; Jedrzkiewicz S; Gao D; Chandna H; Nelson WB; Goodman SG;
Cardiology; 2024; 149(3):266-274. PubMed ID: 38290490
[TBL] [Abstract][Full Text] [Related]
5. Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany.
Waßmuth S; Rohe K; Noack F; Noutsias M; Treede H; Schlitt A
Vasc Health Risk Manag; 2019; 15():477-483. PubMed ID: 31802881
[TBL] [Abstract][Full Text] [Related]
6. Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
Engebretsen I; Bugge C; Støvring H; Husebye E; Sverre E; Dammen T; Halvorsen S; Munkhaugen J
Atherosclerosis; 2024 Jun; 393():117550. PubMed ID: 38657552
[TBL] [Abstract][Full Text] [Related]
7. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
[TBL] [Abstract][Full Text] [Related]
8. Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany.
Koenig W; Lorenz ES; Beier L; Gouni-Berthold I
Clin Res Cardiol; 2024 Jun; 113(6):812-821. PubMed ID: 37603070
[TBL] [Abstract][Full Text] [Related]
9. Association of Use and Dose of Lipid-Lowering Therapy Post Acute Myocardial Infarction With 5-Year Survival in Older Adults.
Fayol A; Schiele F; Ferrières J; Puymirat E; Bataille V; Tea V; Chamandi C; Albert F; Lemesle G; Cayla G; Weizman O; Simon T; Danchin N;
Circ Cardiovasc Qual Outcomes; 2024 May; 17(5):e010685. PubMed ID: 38682335
[TBL] [Abstract][Full Text] [Related]
10. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
Ferrieres J; De Ferrari GM; Hermans MP; Elisaf M; Toth PP; Horack M; Brudi P; Lautsch D; Bash LD; Baxter CA; Ashton V; Ambegaonkar B; Gitt AK
Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
[TBL] [Abstract][Full Text] [Related]
11. Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy - An Observational Pharmacy Claims Database Study.
Umeda T; Hayashi A; Fujimoto G; Piao Y; Matsui N; Tokita S
Circ J; 2019 Jul; 83(8):1689-1697. PubMed ID: 31281135
[TBL] [Abstract][Full Text] [Related]
12. An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome.
Drexel H; Coats AJS; Spoletini I; Bilato C; Mollace V; Perrone Filardi P; Rosano GMC
Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):115-121. PubMed ID: 31873726
[TBL] [Abstract][Full Text] [Related]
13. Treatment of dyslipidemia in acute coronary syndrome.
Yadav S; Sawhney JPS
Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S51-S57. PubMed ID: 38307382
[TBL] [Abstract][Full Text] [Related]
14. Current status of lipid management in acute coronary syndrome.
Fujisue K; Tsujita K
J Cardiol; 2017 Aug; 70(2):101-106. PubMed ID: 28325524
[TBL] [Abstract][Full Text] [Related]
15. Impact of early initiation of ezetimibe in patients with acute coronary syndrome: A systematic review and meta-analysis.
Mahajan K; Nagendra L; Dhall A; Dutta D
Eur J Intern Med; 2024 Jun; 124():99-107. PubMed ID: 38336550
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.
Wallach-Kildemoes H; Hansen EH
Eur J Clin Pharmacol; 2015 Oct; 71(10):1245-54. PubMed ID: 26227068
[TBL] [Abstract][Full Text] [Related]
17. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease.
Cannon CP; Khan I; Klimchak AC; Reynolds MR; Sanchez RJ; Sasiela WJ
JAMA Cardiol; 2017 Sep; 2(9):959-966. PubMed ID: 28768335
[TBL] [Abstract][Full Text] [Related]
18. Lipid management in ACS: Should we go lower faster?
Gencer B; Mach F
Atherosclerosis; 2018 Aug; 275():368-375. PubMed ID: 30015301
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Different Statin-Based Lipid-Lowering Strategies on C-Reactive Protein Levels in Patients With Stable Coronary Artery Disease.
Xue Z; Ye M; Jiang H; Li D; Hong X; Chen Z; Li Y; Zhou B; Zhang W; Wang M
Clin Cardiol; 2024 Jun; 47(6):e24301. PubMed ID: 38895772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
